[gdlr_core_button button-text="See the Webinar" button-link="https://attendee.gotowebinar.com/recording/5834975572267909131" button-link-target="_blank" margin-right="20px" ]
The TGA is re-examining the clinical evidence for medical cannabis - including over-the-counter CBD This is the third article in our series about the Department of Health's submission to the…
Department of Health releases new medical cannabis patient access info The TGA tends to avoid speaking about prescriptions because they have no direct oversight regarding scripts. Instead they focus on…
Department of Health provides new commercial insights to Senate Inquiry The Senate Inquiry into the current barriers to patient access to medicinal cannabis in Australia has already revealed some fascinating…
FreshLeaf’s top ten 2020 trends for Australia’s medical cannabis industry You don’t need a crystal ball to know that 2020 is going to be a big year for cannabis in…
© 2022 All rights reserved, FreshLeaf Analytics
The H2 2021 report is FreshLeaf Analytics’ seventh market
report on patients, products and pricing in the Australian
medicinal cannabis market.
